Exasol AG (CHIX:EXLd)
€ 3.87 (0%) Market Cap: 70.18 Mil Enterprise Value: 50.50 Mil PE Ratio: 353.75 PB Ratio: 16.45 GF Score: 72/100

Preliminary Q4 2024 Exasol AG Earnings Call Transcript

Feb 19, 2025 / 10:59 AM GMT
Release Date Price: €3.87

Key Points

Positve
  • Exasol AG (XTER:EXL) achieved profitability in 2024 with an EBITDA of €2 million, surpassing initial expectations.
  • The company reported a positive net income and cash flow, marking a significant turnaround from previous loss-making years.
  • Total revenue grew by 13% year over year, reaching €39.6 million.
  • Exasol AG increased its cash balance to €15 million by the end of 2024.
  • The company saw strong growth momentum in its focused verticals, particularly in finance, healthcare, and insurance, with a 90% year-over-year growth.
Negative
  • Exasol AG experienced a higher churn rate in non-focused verticals, impacting overall net ARR performance.
  • The company anticipates a decline in ARR in the first half of 2025 due to seasonality and customer churn.
  • A significant customer in the UK churned, contributing to a larger ARR decline in Q2 2024.
  • The non-focused verticals saw a net decline of 12% in 2024, dragging down overall growth.
  • Exasol AG faces challenges with exploding computing costs in the cloud, which is a significant concern for customers.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

EXLn.DE - Exasol AG
Preliminary Q4 2024 Exasol AG Earnings Call
Feb 19, 2025 / NTS GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good day, ladies and gentlemen, and a warm welcome to today's earnings call of the EASOL AG following the publication of the preliminary financial year figures of 2024. I'm delighted to welcome CEO Jo Tevis and CFO Janer Henrich. So the gentlemen will speak shortly and guide us through the presentation and the results, and afterwards we will have our Q&A session, so there you have the opportunity to ask your questions if you may have.

So having said this, Mr. Tavis, the stage is yours.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Sarah. Good afternoon, everybody.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot